baber/WOPTO huggingface dataset:
Patent ID-28029-A (ID)
Inventor: ASHCROFT ALEXANDER THOMAS
IPC: A61P1/02
Filed: 1999-07-23
Abstract: The present invention relates to a toothpaste which comprises particulate calcium carbonate as the main abrasive cleaning agent. By using a mixture of relatively fine particulate calcium carbonate with a certain level of relatively coarse particulate calcium carbonate, the toothpaste provides for a reduced RDA while maintaining the same cleaning efficacy in comparison with the use of only the relatively fine particulate calcium carbonate.
Patent IL-100703-A (IL)
Title: Cutting insert having a circular cutting edge with a chip former
IPC: B23B27/14
Filed: 1992-01-20
Abstract: A metal cutting tip having an upper face (5) and a curved relief face defining (4) between them a substantially circular cutting edge (6); a chip former located in said upper face (5) and comprising a plurality of substantially radially directed recesses (8) formed in said upper face (5) and respectively extending from and merging smoothly with, a land surface (7) adjacent to and coextensive with said cutting edge (6) to, and merging smoothly with, a substantially centrally located deflector wall (9); adjacent recesses (8) intersecting at substantially radially directed rectilinear ridges (11), each ridge (11) merging smoothly at one end thereof with a component rake surface (12) extending smoothly from said land surface (7) and at an opposite end thereof, with said deflector wall (9). <IMAGE>
Patent IL-103325-A (IL)
Title: Process for the production of soluble instant coffee in powder form
IPC: A23F5/26
Filed: 1992-10-02
Abstract: Process for producing soluble instant coffee powder by separate extraction of the ground roast coffee contained in percolation cells, producing a first liquid extract originating from the atmospheric stage (1) and a second liquid extract originating from the pressurised stage (2), the first liquid extract being evaporated off to a solids concentration greater than 35% by weight and the second liquid extract being evaporated off to a solids concentration lower than 25% by weight, the two liquid extracts then being mixed, the evaporation vapours of the first liquid extract being condensed and concentrated, the concentrate obtained being reintroduced into the continuation of the process for converting the mixture into soluble coffee powder. <??>Application to the production of an instant coffee powder by separate extraction. <IMAGE> 
[EP0538512A1]
Patent IL-104152-A (IL)
Title: Stabilized pharmaceutical preparation comprising growth hormone and histidine
IPC: A61K47/36
Filed: 1992-12-18
Abstract: A pharmaceutical preparation comprising a growth hormone and histidine or a derivative of histidine as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved preparation at ambient temperature. Crystallization of growth hormone in the presence of histidine or a derivative thereof gives rise to a higher yield of crystals having a higher purity than known methods.
Patent IL-104634-A (IL)
Title: Thiazole derivatives of alkoxyacrylates with fungicidal activity their preparation and compositions containing them
Inventor: CAMAGGI GIOVANNI
IPC: C07D513/04
Filed: 1993-02-05
Abstract: Compounds based on derivatives of pyrrole[2,1-b]- and imidazo[2,1-b-]thiazoles, with a fungicidal activity, having the general formula (I): <CHEM> i
Patent IL-107607-A (IL)
Title: Method and system for automatically inspecting ophthalmic lenses
IPC: G01N21/88
Filed: 1993-11-14
Abstract: A method for automatically inspecting an ophthalmic lens, comprising: directing a light beam through the lens (80) and onto an array of pixels (46); assigning to each pixel a data value representing the intensity of the light beam on the pixel; and processing said data values according to a predetemined program to determine if the lens contains any one of a plurality of predetermined conditions.
Patent IL-128745-A (IL)
Title: Pharmaceutical microspheres containing valproic acid for oral administration
IPC: A61P25/08
Filed: 1997-10-03
Abstract: Pharmaceutical microspheres, containing, as active principle, a mixture of valproic acid and of one of its pharmaceutically acceptable salts in combination with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols or waxes and their mixtures.
Patent IL-135722-A (IL)
Title: Intensive multidirectional phototherapy device
IPC: A61N5/06
Filed: 1998-10-30
Abstract: Disclosed is a phototherapy device for treating icterus in new-born patients, comprising a light box with at least one light source arranged in the box for illuminating the patient and a support for the patient to be placed upon which is at least partially transparent or tinted as to allow the light from the light box to expose the patient from below with respect to its direction of gravity, making it possible to expose areas having a high bilirubin concentration which tend to follow the direction of gravity.
Patent IL-137626-A (IL)
Title: Toothed coupling for tracked vehicles
IPC: F16D11/14
Filed: 2000-08-01
Abstract: The coupling has an inner-toothed, axially moving coupling sleeve (3), which engages a first outer-toothed gear (2) as well as an inner flange (4) and can be brought to engage a second outer-toothed gear (20). The flange is connected to a spindle (9) arranged coaxially inside the coupling sleeve, which co-operates with a spindle nut (10). A stop part (13) for a tool (60) is arranged at the spindle, which can only be removed from the stop part at the fixed axial position of the spindle. An Independent claim is included for a tool for the gear coupling.
Patent IL-138488-A (IL)
Title: Vegf-e polypeptides, nucleic acids encoding the same, process for their preparation, compositions, vectors, host cells and methods using such polypeptides
IPC: C07K14/52
Filed: 2000-09-14
Abstract: The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E can be useful in wound repair, as well as in the generation and regeneration of tissue.
Patent IL-148824-A (IL)
Title: Ultrasound handpiece
IPC: A61F9/007
Filed: 2002-03-21
Abstract: A handpiece having a set of longitudinally vibrating piezoelectric elements (21) and which may additionally have ) an electric motor (114) to provide rotational or oscillatory movement to the ultrasound horn. The piezoelectric elements (21) are surrounded by a high temperature plastic sleeve (39), and the sleeve is filled with high temperature potting material (141). The' potting material seal the piezoelectric elements against moisture without affecting the performance of the piezoelectric elements.
Patent IL-151611-A (IL)
Title: Module specific interface for cellular phones
IPC: H04M1/725
Filed: 2002-02-04
Abstract: A system for connecting between at least one radio communication transceiver and at least one conventional telephone including: (a) at least one detachable adaptor, each adaptor having (i) a cellular transceiver docking connector, the connector operatively connected to the radio communication transceiver, and (ii) an interface module operatively connected to the docking connector, wherein the module is designed and configured for utilization of at least one protocol that enables information transfer between the conventional telephone and the transceiver.
Patent IL-153587-A (IL)
Title: Stabilized interleukin 2
IPC: A61P35/00
Filed: 2002-12-23
Abstract: A stable pharmaceutical preparation comprising Human interleukin-2 or a variant thereof and a stabilizing amount of histidine. A preferred formulation includes glycine and sucrose and a variant of IL-2 having a single mutation, N88R. The preferred formulation is in lyophilized form which, on reconstitution with an aqueous diluent, results in a solution having a pH ranging from about 5.0 to 6.5.
Patent IL-156904-A (IL)
Title: Cutting insert
Inventor: SATRAN AMIR
IPC: B23C/
Filed: 2003-07-14
Abstract: A generally square-shaped indexable cutting insert with four cutting edges for mounting in milling cutters for either slotting operations or for left-hand and right-hand face milling of right-angled corners in a metal workpiece. The cutting edge is parallel to the bottom surface and has a primary cutting edge extending between two wipers, each wiper being adjacent a corner edge. A first relief surface adjacent the primary cutting edge has a first relief angle and a second relief adjacent the two wipers has a second relief angle that is greater than the first relief angle. The first relief surface has a width dimension measured perpendicularly to the cutting edge that has a minimum value proximal to the two wipers and a maximum value at a central region of the cutting edge.
Patent IL-157041-A (IL)
Title: Monoclonal antibodies to the clfa protein and method of use in treating and preventing infections
IPC: A61K39/395
Filed: 2003-07-21
Abstract: Monoclonal antibodies which can bind to the ClfA protein and which are generated from binding subdomains or active fragments of the ClfA protein from Staphylococcus aureus, including the active fragments proteins from its fibrinogen binding domain such as Clf40 protein, the Clf33 protein, or ClfA N3, are provided which can be useful in the treatment and protection against infection from staphylococcal bacteria such as Staphylococcus aureus. In addition, medical instruments can be treated using the monoclonal antibodies of the invention in order to reduce or eliminate the possibility of their becoming infected or further spreading the infection. In particular, the antibodies of the present invention are advantageous because they can prevent adherence of the bacteria to host cells by impairing or inhibiting the ability of S. aureus ClfA to bind to fibrinogen or fibrin, and thus can be utilized in methods or treating or preventing staphylococcal inventions.
Patent IL-158728-A (IL)
Title: Piperazine oxime derivatives having nk-1 receptor antagonistic acitivity
IPC: A61P35/00
Filed: 2003-11-03
Abstract: The present invention relates to a group of novel piperazine oxime derivatives having interesting NK-1 antagonistic activity. The invention relates to compounds of the general formula (1) wherein: X represents phenyl or pyridyl substituted with 1 or 2 substituents from the group CH3, CF3, OCH3, halogen, cyano and 5-CF3-tetrazol-1-yl; Y represents 2- or 3-indolyl, phenyl, 7-aza-indol-3-yl or 3-indazolyl, 2-naphthyl, 3-benzo[b]thiophenyl, 2-benzofuranyl, which groups may be substituted with one or more halogen or alkyl (1-3C); n has the value 0-3; m has the value 0-2; R1 represents NH2, NH-alkyl (1-3C), dialkyl (1-3C)N, morpholino or morpholino substituted with one or two methyl and/or methoxymethyl groups, thiomorpholino, 1,1-dioxothiomorpholino, 2-, 3- or 4-pyridyl or 4-CH3-piperazinyl; R2 is hydrogen, alkyl (1-4C) or phenyl, or R2 together with (CH2)m wherein m is 1, and the intermediate carbon, nitrogen and oxygen atoms forms an isoxazolyl or a 4,5-dihydroisoxazolyl group; R3 and R4 independently represent hydrogen or methyl, or R3 and R4 together are oxygen. The invention also relates to a method for the preparation of the novel compounds, and to pharmaceutical compositions comprising compounds with formula (1) as an active ingredient and the use of these compounds for the treatment of disorders in which neurokinin-1 receptors are involved
Patent IL-176728-A (IL)
Title: Satellite/hands-free interlock systems and/or companion devices for radioterminals and related methods
IPC: H04W88/06
Filed: 2006-07-06
Abstract: A radioterminal may include a transceiver, a hand-held interface coupled to the transceiver, and an interlock coupled to the transceiver. The transceiver may be configured to transmit and receive wireless communications, and the transceiver may be further configured to transmit high power communications at a high maximum power and/or EIRP and to transmit low power communications at a low maximum power and/or EIRP. The interlock may be configured to prevent the transceiver from transmitting high power communications at a power and/or EIRP that exceeds a threshold when the hand-held interface is activated. Related methods are also discussed.
Patent IL-176804-A (IL)
Title: Launched object of missile type for observing the ground
IPC: F42B12/36
Filed: 2006-07-12
Abstract: The machine has a lifting and displacing propulsive unit (3) and an altitude propulsive unit (5) which are placed on both sides of centre of gravity of the machine. The position of the centre of gravity remains fixed, during the combustion of propulsive loads of the propulsive units. The unit (3) has a mass less than that of the unit (5) and close to the centre of gravity of the machine.
Patent IL-179400-A (IL)
Title: Purine derivatives as adenosine a1 receptor agonists and compositions comprising them
IPC: C07D473/34
Filed: 2006-11-20
Abstract: The invention relates to Purine Derivatives, compositions comprising an effective amount of a Purine Derivative; and methods for reducing an animal's rate of metabolism, protecting an animal's heart against myocardial damage during cardioplegia; or for treating or preventing a cardiovascular disease, a neurological disorder, an ischemic condition, a reperfusion injury, obesity, or wasting disease, or diabetes, comprising administering an effective amount of a Purine Derivative to an animal in need thereof.
Patent IL-181437-A (IL)
Title: Medium and method for culturing undifferentiated stem cells
IPC: C12N5/0735
Filed: 2007-02-19
Abstract: Previous methods for culturing primate pluripotent stem cells have required either fibroblast feeder cells or a medium which was exposed to fibroblast feeder cells to maintain the stem cells in an undifferentiated state. It has now been found that high levels of fibroblast growth factor in a medium together with at least one of gamma aminobutyric acid, pipecolic acid, and lithium, enables pluripotent stem cells to remain undifferentiated indefinitely through multiple passages, even without feeder cells or conditioned medium. Without beta-mercaptoethanol, the medium improves cloning efficiency. Also, a matrix of human proteins can be used to culture the undifferentiated cells without exposing the cells to animal products. Further disclosed are new primate pluripotent cell lines made using the defined culture conditions, including the medium and the matrix. Such new cell lines will have never been exposed to animal cells, animal products, feeder cells or conditioned medium.
Patent IL-182431-A (IL)
Title: Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
Filed: 2007-04-10
Abstract: The invention relates to compounds of the formula (I)   
wherein 
n 
is 0, 1 or 2; 
G 
is CH 2  or CHR 3 ; 
R 1  
is H, C 1 -C 6 -alkyl, C 1 -C 6 -alkyl substituted by C 3 -C 6 -cycloalkyl, C 1 -C 6 -hydroxyalkyl, fluorinated C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, fluorinated C 3 -C 6 -cycloalkyl, C 3 -C 6 -alkenyl, fluorinated C 3 -C 6 -alkenyl, formyl, acetyl or propionyl; 
R  2  R 3  and R 4  
are, independently of each other, H, methyl, fluoromethyl, difluoromethyl, or trifluoromethyl; 
A 
is phenylene, pyridylene, pyrimidylene, pyrazinylene, pyridazinylene or thiophenylene, which can be substituted by one ore more substituents selected from halogen, methyl, methoxy and CF 3 ; 
E 
is NR 5  or CH 2 , wherein R 5  is H or C 1 -C 3 -alkyl; 
Ar 
is a cyclic radical selected from the group consisting of phenyl, a 5- or 6-membered heteroaromatic radical comprising as ring members 1, 2 or 3 heteroatoms selected from N, O and S and a phenyl ring fused to a saturated or unsaturated 5- or 6-membered carbocyclic or heterocyclic ring, where the heterocyclic ring comprises as ring members 1, 2 or 3 heteroatoms selected from N, O and S and/or 1, 2 or 3 heteroatom-containing groups each independently selected from NR 8 , where R 8  is H, C 1 -C 4 -alkyl, fluorinated C 1 -C 4 -alkyl, C 1 -C 4 -alkylcarbonyl or fluorinated C 1 -C 4 -alkylcarbonyl, and where the cyclic radical Ar may carry 1, 2 or 3 substituents R a , wherein the variable R a  has the meanings given in the claims and in the description;  
and physiologically tolerated acid addition salts thereof.  The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
Patent IL-185249-A (IL)
Title: Register read for volatile memory
Filed: 2007-08-13
Abstract: Data not stored in the DRAM array (104) of a SDRAM module (100) is read from the SDRAM module (100) in a synchronous data transfer. The data transfer, referred to as register read command/operation, resembles a read command/operation directed to data stored in the DRAM array in timing and operation. The register read command is distinguished by a unique encoding of the SDRAM control signals and bank address bits. In one embodiment, the register read command comprises the same control signal states as a MRS or EMRS command, with the bank address set to a unique value, such as 2'b10. The register read command may read only a single datum, or may utilize the address bus to address a plurality of data not stored in the DRAM array. The register read operation may be a burst read, and the burst length may be defined in a variety of ways.
Patent IL-187078-A (IL)
Title: Compositions comprising aav vector having a serotype 1 capsid and encoding a biologically active molecule for treating a mammal having lysosomal storage disease or alzheimer's disease
IPC: C12N/
Filed: 2007-11-01
Abstract: The disclosure pertains to methods and compositions for treating disorders affecting the central nervous system (CNS). These disorders include neurometabolic disorders such as lysosomal storage diseases that affect the central nervous system, e.g. Niemann-Pick A disease. They also include disorders such as Alzheimer's disease. The disclosed methods involve contacting an axonal ending of a neuron with a composition containing high titer AAV carrying a therapeutic transgene so that the AAV vector is axonally transported in a retrograde fashion and transgene product is expressed distally to the administration site.
Patent IL-187506-A (IL)
Title: Container with hollow needle
IPC: B67D7/74
Filed: 2007-11-20
Abstract: The container (1) has an envelope (6) that is closed up to an opening (7) for delivering the medicine, an arrangement for connecting (4) the opening to an administration device, whereby the container is designed so that the medicine is delivered by varying at least one region of the envelope, which is made in one piece. Independent claims are also included for the following: (A) a method of manufacturing an inventive device (B) and a device for administering a medicine.
Patent IL-191627-A (IL)
Title: Beta glycolipids as immuno-modulators
Inventor: YARON ILAN
Filed: 2008-05-22
Abstract: The invention relates to the use of β-glycolipids as immunomodulators. More particularly, the invention relates to the use of β-glycolipids, preferably, β-lactosyl-ceramide, β-glucosylceramide, β-galactosyl-ceramide, ceramid and β-lactosyl-ceramide, as well as any mixture or combination thereof for the treatment of immune related disorders. The present invention further relates to a process for the modulation of the Th1/Th2 cell balance toward anti-inflammatory cytokine producing cells, in a subject suffering from an immune related disorder. Therapeutic compositions and method for the preparation of these compositions are also provided.
Patent JP-S59131602-A (JP)
Inventor: JIYATSUKU GARAPON
IPC: C10L10/14
Filed: 1983-06-03
Abstract: (57)【要約】本公報は電子出願前の出願データであるた め要約のデータは記録されません。
Patent JP-H06194142-A (JP)
Title: Automatic judging method for protoplast
Inventor: KINOSHITA TATSUYUKI
IPC: C12Q1/04
Filed: 1991-05-01
Abstract: PURPOSE:To provide the method automatically judging a protoplast basing on the feature of the shape of the protoplast image. CONSTITUTION:An image having an area of a certain value or above, the aspect ratio of a certain value or below, the normalized distance error sum of a certain value or below, and the normalized distance error maximum value of a certain value or below is extracted from among images of cells and judged as a protoplast.
Patent JP-H04309016-A (JP)
Title: Opening and closing device of cover
Inventor: UN KIMUCHIYAI
IPC: H04B1/08
Filed: 1991-04-05
Abstract: PURPOSE:To realize the closing and opening device for a cover without caring about its missing and being not detached from the main body in the opening state, capable of being simply opened/closed by slide operation of a finger. CONSTITUTION:An opening/closing device of a cover 21 covering a battery container 25 is provided with a connection part 31 having click mechanisms 32, 33 to the battery cover 21 and the connection part 31 is linked with a hinge pin 29 having a projection 30. Thus, the battery cover 21 is fixed by click at the battery contained and the battery cover 21 is turned freely by a guide of the hinge pin 29 and is not escaped from a cabinet 12.
Patent JP-H10284493-A (JP)
Title: Interconnection and display apparatus using the same
Inventor: KAMIYA KENJI
IPC: H01L21/28
Filed: 1997-04-04
Abstract: PROBLEM TO BE SOLVED: To reduce resistance of an interconnection consisting of scan lines including gate electrodes and to prevent hillocks and pin holes from being generated in the interconnection in an active matrix type liquid crystal display apparatus having a thin film transistor. SOLUTION: An interconnection made of Al-Nd-Ti alloy thin film 22 is formed on a glass substrate 21. In this interconnection composition, when Nd content is set at 0.75 at.% and Ti content is set at 0.5 at%, the resistivity results in approximately 8 μΩcm. Thus, even when a heat treatment is carried out at the temperature of 240-270 deg.C after formation of the interconnection, generation of hillocks and pin holes can be suppressed.
Patent JP-S63265478-A (JP)
Title: Laser device
Inventor: YASUI KIMIHARU
IPC: H01S3/034
Filed: 1987-04-23
Abstract: PURPOSE:To improve light condensing characteristics by a method wherein a magnifying mirror is composed of a concave or convex mirror made of transparent optical material and a non-reflective coating film is not applied to the center part of its surface facing a collimating mirror and the non-reflective coating film is applied to the surface except the center part. CONSTITUTION:A non-reflective coating film 5 is applied to the inside surface, i.e. the surface facing a collimate mirror 1, of a convex mirror 4 which also serves as a window mirror in an annular shape except the center part and a non-reflective coating film 5 is also applied to the whole outside surface of the convex mirror 4. A laser beam 7 reflected and magnified by the center part 20 of the convex mirror 4 is amplified by a laser medium 3 and, at the same time, collimated into a parallel beam by the collimating mirror 1 taken outside through the convex mirror 4 as a laser beam 8. The laser beam 8 is composed of a part transmitted through the center part 20 which is not coated with the non-reflective coating film 5 and a part transmitted through the non-reflective coating film 5. As the part transmitted through the center part 20 has a partially transmitting property, the inside of the laser beam 8 is filled and the ratio, M value, of the outer diameter to the inner diameter of an annular beam corresponds to infinity. With this constitution, a large power and high quality laser beam can be taken out.